Aberrant expression of FGFR2 can contribute to the proliferation of some malignant cancers such as gastric cancer [40], prostate cancer [41] and esophageal carcinoma [42] and facilitates cell survival in many different cancers including prostate cancer, breast cancer, and gastric cancer [43]. Here, FGFR2 is linked to gastric cancer.